Profile
ACIU VRTX ALNY REGN ARGX SGEN
Company Name AC Immune S.A. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $354.22M $100.41B $59.77B $58.74B $48.87B $43.15B
Employees 0.13K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Andrea Pfeifer Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
ACIU VRTX ALNY REGN ARGX SGEN
Quant Rating Score 1 3 1 4 3 3
Quant Rating Strong Sell Neutral Strong Sell Buy Neutral Neutral
Trading
ACIU VRTX ALNY REGN ARGX SGEN
Last Close $3.52 $421.15 $450.68 $563.86 $798.94 $228.74
High 52 $3.99 $516.74 $482.13 $1016.53 $800 $228.74
Low 52 $1.48 $366.54 $224.58 $482.92 $520.52 $228.74
Price vs. 52 Week High -11.78 % -18.5 % -6.52 % -44.53 % -0.13 % 0 %
Price vs. 52 Week Low 137.84 % 14.9 % 100.68 % 16.76 % 53.49 % 0 %
Total Return
ACIU VRTX ALNY REGN ARGX SGEN
1 Month Return 60 % 6.22 % -6.52 % 1.32 % 4.1 % 0 %
3 Month Return 69.23 % -12.07 % 40.53 % 2.06 % 43.9 % 0 %
6 Month Return 130.07 % -12.68 % 85.28 % -2.14 % 41.7 % 0 %
9 Month Return 25.71 % 2.19 % 87.35 % -23.14 % 23.05 % 0 %
YTD Return 30.37 % 4.58 % 91.53 % -20.84 % 29.91 % 0 %
1 Year Return 3.83 % -10 % 66.36 % -44.29 % 53.49 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACIU VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -42.88 % 11.09 % -0.43 % 4.37 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
ACIU VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 100 % 86.11 % 83.64 % 81.98 % 65.82 % 79.1 %
Return on Assets TTM -26.55 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -49.04 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -54.91 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100.01 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 100.8 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -173.27 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -866.5 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Receivables Turnover TTM 13.57 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 5.31 3.59 3.93 3.54 0.9 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.26 0.96
Fixed Asset Turnover TTM 389.94 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 15.2 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.42 14.98 -0.12 45.13 5.67 -2.46
Free Cash Flow Per Share TTM -0.43 13.63 -0.4 36.58 5.58 -2.88
Cash Per Share TTM 126.34 % 2486.48 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -147.39 % 33.68 % -0.63 % 33.37 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.33 % 90.99 % 335.21 % 81.05 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -866.5 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM -6.48 28.69 -1147.52 15.28 122.57 -81.26
Price To Operating Cash Flows Ratio TTM -6.67 26.14 -3805.41 12.49 140 -93.1
Price Cash Flow Ratio TTM -6.67 26.14 -3805.41 12.49 140 -93.1
Income Statement (TTM)
ACIU VRTX ALNY REGN ARGX SGEN
Revenue $0.03B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0.03B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.05B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.05B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -0.51 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
ACIU VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.12B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.11B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0.13B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.01B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.23B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
ACIU VRTX ALNY REGN ARGX SGEN
Net Income $-0.05B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $0.07B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 38.3
AARD Aardvark Therapeutics, Inc. Common Stock 16.688
ABCL AbCellera Biologics Inc. 5.99
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.591
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.95
ABPWW 0.0255
ABSI Absci Corporation 4.0216
ABUS Arbutus Biopharma Corporation 4.21
ABVC ABVC BioPharma, Inc. 3.2137
ABVX Abivax SA American Depositary Shares 93.13
ACAD ACADIA Pharmaceuticals Inc. 21.125
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9666
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.36
ACLX Arcellx, Inc. 86.99
ETFs With Exposure to ACIU
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.01826 152.47
GWX SPDR S&P International Small Cap ETF 0.02 40.6843
BIB ProShares Ultra Nasdaq Biotechnology 0.0182045 66.12
SBIO ALPS Medical Breakthroughs ETF 0.002 41.295
BMED BlackRock Future Health ETF 0.0106 27.8877
IBBQ Invesco Nasdaq Biotechnology ETF 0.029 25.635
DFAT Dimensional U.S. Targeted Value ETF 0.0001165 57.8566
DFAS Dimensional U.S. Small Cap ETF 0.00000797 68.445
DFAC Dimensional U.S. Core Equity 2 ETF 0.00006389 38.75
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02736 6.462
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02736 7.48
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0282 46
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.02736 7.453
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0282 53.51
QQQS Invesco NASDAQ Future Gen 200 ETF 0.406 34.8004
DFSU Dimensional US Sustainability Core 1 ETF 0.00026094 42.645
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02736 5.6025
DXUV Dimensional ETF Trust 0.00002414 58.76
Unlock